Impact of Secukinumab on Patient-Reported Outcomes in the Treatment of Ankylosing Spondylitis: Current Perspectives
Hasan Tahir,1,2 Arumugam Moorthy,3 Antoni Chan4 1Royal Free London NHS Trust, London, UK; 2Division of Medicine, University College London, London, UK; 3University Hospitals of Leicester NHS Trust, Leicester, UK; 4Royal Berkshire NHS Trust, Reading, UKCorrespondence: Hasan TahirRoyal Free London NHS...
Guardado en:
Autores principales: | Tahir H, Moorthy A, Chan A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8851a219e8d84ce2863bdcb761cfbb27 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum IL-6 correlates with axial mobility index (Bath Ankylosing Spondylitis Metrology Index) in Brazilian patients with ankylosing spondylitis
por: Rabelo CF, et al.
Publicado: (2018) -
Serum heat-shock protein-65 antibody levels are elevated but not associated with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
por: Ulusoy H, et al.
Publicado: (2018) -
Efficacy of TNF inhibitors in advanced ankylosing spondylitis with total spinal fusion: case report and review of literature
por: Shim MR
Publicado: (2019) -
The evaluation of bone marrow edema in sacroiliac joint in patients with ankylosing spondylitis using magnetic resonance imaging Dixon sequence
por: Ming-Shan Du, et al.
Publicado: (2021) -
Management of ankylosing spondylitis with infliximab
por: Éric Toussirot, et al.
Publicado: (2009)